Skip to main content

Fernando Moreno Flores

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Clinical Laboratories
Cross-departmental services
Fernando Moreno Flores

Fernando Moreno Flores

Fernando Moreno Flores

Institutions of which they are part

Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Vall Hebron Institut de Recerca
Bioquímic/a Clínic/a
Clinical Laboratories
Cross-departmental services

Related news

Docetaxel, carried by Soluplus, proved to be the most effective and least toxic combination to cross the blood-brain barrier and attack the tumour directly.

Based on the study led by VHIR, a clinical trial has been approved for patients with locally advanced pancreatic cancer.

Vall d'Hebron participates in a project to develop innovative microsampling technology, making blood collection more accessible and patient-centered.

Related professionals

Ana Lain Fernandez

Ana Lain Fernandez

Bioengineering, Cell Therapy and Surgery in Congenital Malformations
Read more
Sabrina Ayelen Gatti

Sabrina Ayelen Gatti

Predoctoral researcher
Neurodegenerative Diseases
Read more
Mercedes Velasco Zarzuelo

Mercedes Velasco Zarzuelo

Research Group of Physical Medicine and Rehabilitation
Read more
Oliver Pacheco Hernández

Oliver Pacheco Hernández

Administrative
Financial Control Unit
Finance Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.